This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.
Device | P130014S003 |
Classification Name | None |
Applicant | |
PMA | P130014 |
Supplement | S003 |
Supplement Number | Date | Supplement Type |
---|---|---|
P130014 | Original Filing | |
S016 | 2022-12-21 | 30-day Notice |
S015 | 2022-03-04 | 30-day Notice |
S014 | 2022-02-09 | 30-day Notice |
S013 | 2021-11-18 | 30-day Notice |
S012 | 2021-08-24 | 30-day Notice |
S011 | 2021-04-13 | 30-day Notice |
S010 | 2021-02-23 | 30-day Notice |
S009 | 2020-11-18 | 30-day Notice |
S008 | 2020-07-17 | 30-day Notice |
S007 | 2020-04-13 | Real-time Process |
S006 | 2019-08-16 | 30-day Notice |
S005 | 2018-02-12 | Normal 180 Day Track No User Fee |
S004 | 2017-05-03 | 30-day Notice |
S003 | ||
S002 | 2016-02-02 | Normal 180 Day Track |
S001 |
Device ID | PMA | Supp |
---|---|---|
00897146002018 | P130014 | 000 |
30897146002026 | P130014 | 002 |